Metabolic and cardio-respiratory responses of four asthmatic and four non-asthmatic athletes to two hours of treadmill running at 70 percent of maximal oxygen uptake are compared. The asthmatic group had pre-exercise airflow obstruction, as indicated by the lower forced expiratory volume in one second (FEV1) even after medication (2.90 ± 0.661) compared to the non-asthmatic group (4.09 ± 1.331). Changes in blood lactate, glucose and catecholamine concentrations as a result of the two hour run were similar for the two groups. However, the pattern of breathing was different. The asthmatics had a slower breathing frequency but a similar tidal volume to the non-asthmatics. Both groups had an increase in the ventilation rate over the two hour run. For the nonasthmatic group, this increase in ventilation was achieved by an increase in the breathing frequency (p<0.01), whereas tidal volume was reduced (p<0.05). The increase in the ventilation rate over the two hour run for the asthmatic group was brought about by a small increase in breathing frequency (p<0.05), whereas tidal volume was not changed. This maintenance of the tidal volume by the asthmatic athletes during endurance running may compensate for the airflow obstruction, and so allow successful participation in endurance running.
likely to provoke exercise-induced asthma (EIA) such as endurance running. Indeed, endurance running training has been shown to improve the fitness of asthmatic children2 and adults without adversely affecting their asthma, thus supporting running as an additional recreational activity for the asthmatic. Despite respiratory impairment, a number of asthmatics engage in endurance running at a competitive level, racing in long distance events such as the half-marathon and marathon.
How do asthmatic athletes who compete in endurance events compensate for their airflow obstruction? Primarily, asthma does not prevent the normal adaptations to endurance running training. This allows asthmatic athletes to sustain a high percentage of their maximal oxygen uptake (VO2 max) during endurance races such as the half-marathon4. Furthermore, there is evidence that trained asthmatics achieve and maintain an enhanced expiratory airflow during progressive maximal exercise, whilst untrained asthmatics are unable to do so5. Although these factors may help to explain why some asthmatics with impaired pulmonary function can compete in sports with high aerobic demands, it would be preferable to evaluate the physiological responses of asthmatic athletes actually engaged in endurance running.
We have previously shown that the cardiorespiratory and metabolic responses to a simulated half-marathon 'race' on a treadmill were similar for asthmatic and non-asthmatic athletes6. However, since the athletes were asked to race the halfmarathon, they were able to change their running speed and so the exercise was not of constant intensity and represented different relative exercise intensities between athletes. Therefore it was not possible to determine whether the asthmatic athlete had an altered physiological response to endurance running compensating for their airflow obstruction.
The aim of the present study was For the two hour run, the athletes came to the laboratory in the morning after an overnight fast. The asthmatic athletes had withheld their medication for six hours (B2 agonists) and 24 hours (disodium cromoglycate). Lung function was measured at rest using a dry-spirometer (Vitalograph Ltd) to obtain the forced expiratory volume in one second (FEV1) and the forced vital capacity (FVC). The asthmatic athletes then took their usual pre-exercise medication and measurements of FEV, and FVC were repeated after 10 
Results
The physical characteristics and maximum exercise performance, along with the running speed and the actual percent V02 max sustained during the two hour run are shown for each athlete in Table 1 . Although the asthmatic group had a lower V02 max and therefore a slower running speed for the two hour run, the exercise intensity did demand approximately 70 percent V02 max for both groups.
Temperature and humidity in the laboratory during the study period ranged from 18.6 to 22.00C and 55 to 78 percent, respectively. The fluid intake was modest for both the asthmatic (254 ± 113 ml) and non-asthmatic (158 ± 128 ml) groups. Both groups lost an average of 2kg or three percent of body weight during the two hour run and the change in plasma volume was -7.8 ± 4.5 percent and -5.9 + 2.9 percent for the asthmatic and non-asthmatic groups, respectively.
The four asthmatic athletes took their usual pre-exercise medication before the two hour run which increased the FEV, slightly in two asthmatics (A and C) and markedly in the other two asthmatics (B and D) as shown in Table 2 . After medication, the FEV, was however still below the predicted normal values, the FVC was normal (4.82 ± 0.391, 102 ± 6 percent predicted) and consequently the FEV1/FVC ratio was low (60 ± 9 percent). The pre-exercise spirometric values for the non-asthmatic group were all within normal limits, with an FEVI of 4 The cardiovascular drift, as indicated by the increase in heart-rate for both groups, is associated with thermoregulatory control. During the two hour run, water intake fell short of the recommendations to replace fluid loss of one litre per hour2l, so that body fluids and hence plasma volume were reduced. Venous return, stroke volume and cardiac output would be reduced as a consequence of the reduced plasma volume, and this, combined with the shunting of blood to the peripheral subcutaneous vessels for thermoregulation , leads to a rise in heart-rate needed to maintain cardiac output.
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Both groups showed a significant upward drift in the ventilation rate over the two hour run, which may be a direct consequence of the increased oxygen uptake'6, although others disagree with this suggested explanation"8. The response in the breathing pattern over time was however different for the two groups. In the non-asthmatic group, the increase in ventilation rate with time was brought about by a significant increase in breathing frequency, whilst tidal volume was significantly reduced, confirming previous observations'8. It is also of note that the pre-exercise medication used by three of the asthmatics would not be allowed for use in international competition. Two asthmatics were taking a combination of disodium cromoglycate and isoprenaline sulphate (Intal Compound); isoprenaline is a stimulant and so substances containing it are banned by the International Olympic Committee2'. Furthermore, one asthmatic was taking pirbuterol hydrochloride (Exirel) which is not one of the five permissable B2 agonists25. Although these asthmatics were not international athletes, this highlights the need for athletes and physicians to be aware of the drugs banned in high level sports participation.
In condusion, asthmatic athletes with airflow obstruction have an altered pattern of breathing when engaged in endurance running which may help to explain why they can compete successfully against non-asthmatics. Furthermore, pre-exercise medication is not always effective in preventing EIA which questions the safety of endurance running for athletes with severe asthma.
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